ISEC Healthcare (SGX:40T) Cyclically Adjusted Revenue per Share: S$0.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:40T ISEC Healthcare Ltd SGX:40T
60 GF Score
Price S$0.31
GF Value S$0.44
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is ISEC Healthcare Cyclically Adjusted Revenue per Share?

ISEC Healthcare SGX:40T 60 Cyclically Adjusted Revenue per Share is S$0.11 as of Jun. 2026. GuruFocus rates SGX:40T with a GF Score™ of 60/100 and a GF Value™ of S$0.44 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ISEC Healthcare's adjusted revenue per share for the three months ended in Jun. 2026 was S$0.039. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is S$0.11 for the trailing ten years ended in Jun. 2026.

During the past 12 months, ISEC Healthcare's average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-25), ISEC Healthcare's current stock price is S$0.31. ISEC Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was S$0.11. ISEC Healthcare's Cyclically Adjusted PS Ratio of today is 2.82.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ISEC Healthcare was 5.22. The lowest was 2.68. And the median was 3.80.


ISEC Healthcare  (SGX:40T) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ISEC Healthcare's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.31/0.11
=2.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ISEC Healthcare was 5.22. The lowest was 2.68. And the median was 3.80.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ISEC Healthcare Cyclically Adjusted Revenue per Share Related Terms


ISEC Healthcare Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for ISEC Healthcare's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ISEC Healthcare Cyclically Adjusted Revenue per Share Chart

ISEC Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.09 0.10 0.11

ISEC Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.11 0.11 0.11 0.11

SGX:40T vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, ISEC Healthcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ISEC Healthcare Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ISEC Healthcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ISEC Healthcare's Cyclically Adjusted PS Ratio falls into.


SGX:40T
60GF Score
ISEC Healthcare Ltd SGX:40T
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ISEC Healthcare Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ISEC Healthcare's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.039/333.9520*333.9520
=0.039

Current CPI (Jun. 2026) = 333.9520.

ISEC Healthcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.015 241.428 0.021
201612 0.017 241.432 0.024
201703 0.016 243.801 0.022
201706 0.018 244.955 0.025
201709 0.019 246.819 0.026
201712 0.018 246.524 0.024
201803 0.019 249.554 0.025
201806 0.020 251.989 0.027
201809 0.019 252.439 0.025
201812 0.020 251.233 0.027
201903 0.019 254.202 0.025
201906 0.020 256.143 0.026
201909 0.020 256.759 0.026
201912 0.022 256.974 0.029
202003 0.017 258.115 0.022
202006 0.010 257.797 0.013
202009 0.020 260.280 0.026
202012 0.018 260.474 0.023
202103 0.016 264.877 0.020
202106 0.018 271.696 0.022
202109 0.015 274.310 0.018
202112 0.024 278.802 0.029
202203 0.021 287.504 0.024
202206 0.029 296.311 0.033
202209 0.032 296.808 0.036
202212 0.030 296.797 0.034
202303 0.030 301.836 0.033
202306 0.031 305.109 0.034
202309 0.032 307.789 0.035
202312 0.030 306.746 0.033
202403 0.029 312.332 0.031
202406 0.032 314.175 0.034
202409 0.033 315.301 0.035
202412 0.035 315.605 0.037
202503 0.031 319.799 0.032
202506 0.035 322.561 0.036
202509 0.036 324.800 0.037
202512 0.036 324.054 0.037
202603 0.032 330.213 0.032
202606 0.039 333.952 0.039

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of S$0.11 mean?
ISEC Healthcare (SGX:40T) has a Cyclically Adjusted Revenue per Share of S$0.11 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ISEC Healthcare and its competitors.
Is ISEC Healthcare's Cyclically Adjusted Revenue per Share too high?
ISEC Healthcare's current Cyclically Adjusted Revenue per Share is S$0.11. Overall, ISEC Healthcare has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ISEC Healthcare's Cyclically Adjusted Revenue per Share compare to HCA and THC?
ISEC Healthcare's Cyclically Adjusted Revenue per Share of S$0.11 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ISEC Healthcare and its competitors. ISEC Healthcare's current Cyclically Adjusted Revenue per Share is S$0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ISEC Healthcare stock overvalued right now?
Based on GuruFocus' analysis, ISEC Healthcare (SGX:40T) is currently considered Significantly Undervalued. The stock's GF Value™ is S$0.44, compared to a current price of S$0.31 — trading 29.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is S$0.11. ISEC Healthcare's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For ISEC Healthcare (SGX:40T), the current Cyclically Adjusted Revenue per Share is S$0.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ISEC Healthcare (SGX:40T) Overvalued in 2026?

Based on GuruFocus' analysis, ISEC Healthcare stock appears to be undervalued. The current stock price of S$0.31 is trading 29.5% below its estimated GF Value™ of S$0.44. GuruFocus considers ISEC Healthcare to be Significantly Undervalued.

Key valuation signals for SGX:40T:

  • Cyclically Adjusted Revenue per Share: S$0.11
  • GF Value™: S$0.44 vs. price of S$0.31 (29.5% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the SGX:40T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ISEC Healthcare Business Description

Address 51 Goldhill Plaza, No. 10-07/08, Singapore, SGP, 308900
ISEC Healthcare Ltd principal activity of the Company is that of an investment holding company. It is regional provider of comprehensive medical eye care services with ambulatory surgical centres. The company has two reportable segment which are Specialised health services: provision of medical care, consultancy, treatment and surgery in the field of ophthalmology; and General health services: provision of general medical and procedural treatment services. The majority of revenue comes from Specialised health services segment. The company has presence in Singapore, Malaysia, and Myanmar. The company generates majority of revenue from Malaysia.
60GF Score

Get the complete analysis for SGX:40T

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.31
Price
S$0.44
GF Value